AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images
Atheroscope
Development and Validation of an AI-Based Tool to Detect Subclinical Atherosclerosis Using Non-Mydriatic Retinal Fundus Images: The AI-THEROSCOPE Project
1 other identifier
observational
884
1 country
1
Brief Summary
Cardiovascular risk scores are widely used for risk stratification but may fail to identify a substantial proportion of individuals with subclinical atherosclerosis who are at increased risk of future cardiovascular events. Vascular ultrasound can directly detect carotid and femoral atherosclerotic plaques but its implementation is limited by the need for trained operators and expert interpretation. The AI-THEROSCOPE study aims to develop and validate an artificial intelligence-based tool capable of detecting subclinical atherosclerosis through the analysis of non-mydriatic retinal fundus images. Participants undergo clinical assessment, laboratory testing, carotid and femoral ultrasound, and retinal fundus photography. The performance of the AI model will be evaluated against vascular ultrasound findings as the reference standard for the presence of subclinical atherosclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedJune 10, 2026
June 1, 2026
2.3 years
June 1, 2026
June 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Area Under the Receiver Operating Characteristic Curve (AUC) for Detection of Subclinical Atherosclerosis
Diagnostic performance of the artificial intelligence model based on non-mydriatic retinal fundus images for detecting carotid and/or femoral atherosclerotic plaques, using vascular ultrasound as the reference standard.
Baseline
Study Arms (1)
Participants Undergoing Retinal Imaging and Vascular Ultrasound
Adult participants without previous established cardiovascular disease who undergo standardized cardiovascular risk assessment, laboratory testing, bilateral carotid and femoral vascular ultrasound, and non-mydriatic retinal fundus photography. The cohort is used for the development and validation of an artificial intelligence model for the detection of subclinical atherosclerosis using retinal fundus images. The presence of carotid and/or femoral atherosclerotic plaque assessed by vascular ultrasound serves as the reference standard.
Eligibility Criteria
Adults undergoing cardiovascular risk assessment at a university hospital cardiovascular risk unit and healthcare workers or relatives participating in cardiovascular screening programs. All participants undergo clinical evaluation, laboratory testing, carotid and femoral vascular ultrasound, and non-mydriatic retinal fundus photography.
You may qualify if:
- Adults aged 18 years or older.
- No previous established cardiovascular disease.
- Undergoing cardiovascular risk assessment and carotid and femoral vascular ultrasound.
- Ability to provide written informed consent.
You may not qualify if:
- Previous acute coronary syndrome, stroke, or peripheral arterial disease.
- Previous carotid or femoral vascular surgery or stenting.
- Previous ophthalmologic surgery.
- Retinal or ocular diseases that significantly affect retinal vasculature or image quality, including moderate or severe diabetic retinopathy, retinal vascular occlusion, advanced hypertensive retinopathy, exudative age-related macular degeneration, or macular edema.
- Inability or unwillingness to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Infanta Leonor
Madrid, Madrid, 28031, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist in Internal Medicine
Study Record Dates
First Submitted
June 1, 2026
First Posted
June 4, 2026
Study Start
October 1, 2023
Primary Completion
January 1, 2026
Study Completion (Estimated)
January 1, 2028
Last Updated
June 10, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared. De-identified data may be made available upon reasonable request to the principal investigator, subject to institutional policies, ethical approval, data protection regulations, and applicable legal requirements.